Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
454.5000 1.90 (0.42%)
NSE Jul 03, 2026 15:31 PM
Volume: 403.8K
 

454.50
0.42%
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Number of FII/FPI investors decreased from 171 to 146 in Mar 2026 qtr
More from Cohance Lifesciences Ltd.
Recommended